标题
Adenovirus vector system: construction, history and therapeutic applications
作者
关键词
-
出版物
BIOTECHNIQUES
Volume 73, Issue 6, Pages 297-305
出版商
Future Science Ltd
发表日期
2022-12-07
DOI
10.2144/btn-2022-0051
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Interim Results of a Phase 1–2a Trial of Ad26.COV2.S Covid-19 Vaccine
- (2021) Jerald Sadoff et al. NEW ENGLAND JOURNAL OF MEDICINE
- Sputnik V COVID-19 vaccine candidate appears safe and effective
- (2021) Ian Jones et al. LANCET
- Delta-24 adenoviral therapy for glioblastoma: evolution from the bench to bedside and future considerations
- (2021) Chibawanye I. Ene et al. Neurosurgical Focus
- Safety, tolerability, and immunogenicity of a recombinant adenovirus type-5 vectored COVID-19 vaccine: a dose-escalation, open-label, non-randomised, first-in-human trial
- (2020) Feng-Cai Zhu et al. LANCET
- High-Capacity Adenoviral Vectors Permit Robust and Versatile Testing of DMD Gene Repair Tools and Strategies in Human Cells
- (2020) Marcella Brescia et al. Cells
- Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial
- (2020) Pedro M Folegatti et al. LANCET
- Efficient Editing of an Adenoviral Vector Genome with CRISPR/Cas9
- (2020) Qiang Li et al. INDIAN JOURNAL OF MICROBIOLOGY
- Combined effect of recombinant human adenovirus p53 and curcumin in the treatment of liver cancer
- (2020) Juan Qu et al. Experimental and Therapeutic Medicine
- Long-term correction of hemophilia B using adenoviral delivery of CRISPR/Cas9
- (2019) Calvin J. Stephens et al. JOURNAL OF CONTROLLED RELEASE
- Delivering CRISPR: a review of the challenges and approaches
- (2018) Christopher A. Lino et al. DRUG DELIVERY
- Targeted in vivo knock-in of human alpha-1-antitrypsin cDNA using adenoviral delivery of CRISPR/Cas9
- (2018) Calvin J. Stephens et al. GENE THERAPY
- Transducing Airway Basal Cells with a Helper-Dependent Adenoviral Vector for Lung Gene Therapy
- (2018) Huibi Cao et al. HUMAN GENE THERAPY
- Development of novel vaccine vectors: Chimpanzee adenoviral vectors
- (2018) Jingao Guo et al. Human Vaccines & Immunotherapeutics
- Improving adenoviral vectors and strategies for prostate cancer gene therapy
- (2018) RE Tamura et al. Clinics
- Refining strategies to translate genome editing to the clinic
- (2017) Tatjana I Cornu et al. NATURE MEDICINE
- Dual Antagonism of PDGF and VEGF in Neovascular Age-Related Macular Degeneration
- (2017) Glenn J. Jaffe et al. OPHTHALMOLOGY
- Chimpanzee adenoviral vectors as vaccines for outbreak pathogens
- (2017) Katie Ewer et al. Human Vaccines & Immunotherapeutics
- Gene Editing with Helper-Dependent Adenovirus Can Efficiently Introduce Multiple Changes Simultaneously over a Large Genomic Region
- (2017) Donna J. Palmer et al. Molecular Therapy-Nucleic Acids
- Oncolytic Adenoviruses Armed with Tumor Necrosis Factor Alpha and Interleukin-2 Enable Successful Adoptive Cell Therapy
- (2017) Riikka Havunen et al. Molecular Therapy-Oncolytics
- In vitro CRISPR-Cas9-mediated efficient Ad5 vector modification
- (2016) Lichun Tang et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Recent advances in oncolytic adenovirus therapies for cancer
- (2016) Amanda Rosewell Shaw et al. Current Opinion in Virology
- Adenoviral vector-based strategies against infectious disease and cancer
- (2016) Chao Zhang et al. Human Vaccines & Immunotherapeutics
- Phase I study with ONCOS-102 for the treatment of solid tumors – an evaluation of clinical response and exploratory analyses of immune markers
- (2016) Tuuli Ranki et al. Journal for ImmunoTherapy of Cancer
- Adenovirus vectors as HIV-1 vaccines
- (2015) Marie Patricia DʼSouza et al. AIDS
- Safety and immunogenicity of a novel recombinant adenovirus type-5 vector-based Ebola vaccine in healthy adults in China: preliminary report of a randomised, double-blind, placebo-controlled, phase 1 trial
- (2015) Feng-Cai Zhu et al. LANCET
- Oncolytic viruses: a new class of immunotherapy drugs
- (2015) Howard L. Kaufman et al. NATURE REVIEWS DRUG DISCOVERY
- Fiber-Modified Adenovirus for Central Nervous System Parkinson’s Disease Gene Therapy
- (2014) Travis Lewis et al. Viruses-Basel
- The effect of adenovirus-conjugated NDRG2 on p53-mediated apoptosis of hepatocarcinoma cells through attenuation of nucleotide excision repair capacity
- (2013) Wei Cao et al. BIOMATERIALS
- Coagulation factor X shields adenovirus type 5 from attack by natural antibodies and complement
- (2013) Zhili Xu et al. NATURE MEDICINE
- Multiplex Genome Engineering Using CRISPR/Cas Systems
- (2013) L. Cong et al. SCIENCE
- Adenovirus DNA Replication
- (2013) R. C. Hoeben et al. Cold Spring Harbor Perspectives in Biology
- The Critical Role of Vascular Endothelial Growth Factor in Tumor Angiogenesis
- (2012) A. Amini et al. CURRENT CANCER DRUG TARGETS
- Virus chimeras for gene therapy, vaccination, and oncolysis: adenoviruses and beyond
- (2012) Johanna K. Kaufmann et al. TRENDS IN MOLECULAR MEDICINE
- Production of adenovirus vectors and their use as a delivery system for influenza vaccines
- (2010) Sai V Vemula et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Stepwise Loss of Fluorescent Core Protein V from Human Adenovirus during Entry into Cells
- (2010) D. Puntener et al. JOURNAL OF VIROLOGY
- Oncolytic Adenoviruses for the Treatment of Human Cancer: Focus on Translational and Clinical Data
- (2010) Sari Pesonen et al. MOLECULAR PHARMACEUTICS
- Persistence of High-Capacity Adenoviral Vectors as Replication-Defective Monomeric Genomes In Vitro and in Murine Liver
- (2009) Lorenz Jager et al. HUMAN GENE THERAPY
- A simplified in vitro ligation approach to clone an E1B55k-deleted double-targeted conditionally-replicative adenovirus
- (2009) Yosef S Haviv Virology Journal
- Genetic reconstitution of the human Adenovirus type 2 temperature-sensitive 1 mutant defective in endosomal escape
- (2009) Nicola Imelli et al. Virology Journal
- From the first to the third generation adenoviral vector: What parameters are governing the production yield?
- (2008) E. Dormond et al. BIOTECHNOLOGY ADVANCES
- The failed HIV Merck vaccine study: a step back or a launching point for future vaccine development?
- (2008) Rafick-Pierre Sekaly JOURNAL OF EXPERIMENTAL MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More